Barclays’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4538 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | – | – | 4521 |
|
|
2017
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4283 |
|
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4232 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4228 |
|
|
2017
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4244 |
|
|
2016
Q4 | $0 | Sell |
1
-10,872
| -100% | – | ﹤0.01% | 4101 |
|
|
2016
Q3 | $199K | Sell |
10,873
-11,126
| -51% | -$204K | ﹤0.01% | 2137 |
|
|
2016
Q2 | $234K | Buy |
21,999
+21,899
| +21,899% | +$233K | ﹤0.01% | 2053 |
|
|
2016
Q1 | $0 | Sell |
100
-647
| -87% | – | ﹤0.01% | 3815 |
|
|
2015
Q4 | $15K | Sell |
747
-2,186
| -75% | -$43.9K | ﹤0.01% | 2753 |
|
|
2015
Q3 | $118K | Buy |
2,933
+2,248
| +328% | +$90.4K | ﹤0.01% | 2317 |
|
|
2015
Q2 | $14K | Buy |
685
+13
| +2% | +$266 | ﹤0.01% | 3151 |
|
|
2015
Q1 | $14K | Sell |
672
-2,332
| -78% | -$48.6K | ﹤0.01% | 3267 |
|
|
2014
Q4 | $60K | Buy |
3,004
+1,180
| +65% | +$23.6K | ﹤0.01% | 2923 |
|
|
2014
Q3 | $37K | Sell |
1,824
-1,450
| -44% | -$29.4K | ﹤0.01% | 3146 |
|
|
2014
Q2 | $65K | Sell |
3,274
-418
| -11% | -$8.3K | ﹤0.01% | 2939 |
|
|
2014
Q1 | $74K | Sell |
3,692
-222
| -6% | -$4.45K | ﹤0.01% | 2944 |
|
|
2013
Q4 | $156K | Buy |
3,914
+3,714
| +1,857% | +$148K | ﹤0.01% | 2784 |
|
|
2013
Q3 | $8K | Sell |
200
-604
| -75% | -$24.2K | ﹤0.01% | 3708 |
|
|
2013
Q2 | $43K | Buy |
+804
| New | +$43K | ﹤0.01% | 3399 |
|